BCB Group offers solutions for monitoring and analysing different disease groups through integrated proprietary platforms that use real-world data. In the near future, the company aims to strengthen its expertise and offering in the Life Science sector. For that purpose, the first phase of cooperation between BCB Group and Korhonen will focus on the use of RWE, real-world evidence.
Pasi Korhonen has extensive experience in data science and pharmaceutical industry. He is also a serial entrepreneur in RWE business and clinical trials. One of his companies, StatFinn – EPID Research, founded in 2005, operated in five countries and was acquired by IQVIA in 2018. Most recently, Korhonen has worked as a consultant through his own company that provides strategic advice and scientific leadership to clients.
Korhonen has an academic background in statistics and biostatistics. He has been a senior researcher in numerous research projects and held the position of a Professor of Biostatistics at the University of Turku.
Pasi Korhonen comments on the new cooperation: “When I was approached by Patrik Sobocki and Petteri Viljanen and offered this opportunity, I was honoured and inspired. BCB Group is an important player in the field, and I’ve long been impressed by their overall approach, their solutions, and their contribution to knowledge management. I see ample opportunities for success for BCB Group in the Life Science sector.
For example, I believe that in the future, data and analytics can offer the pharmaceutical industry disease specific real-world data solutions and a way to move from clinical trials to digital trials. This will be an important step for the safety of medicinal products.”
BCB Group CEO Patrik Sobocki welcomes Pasi Korhonen as a Strategic Advisor of the BCB Group Leadership Team: “I am delighted that Pasi has agreed to join us in our growth journey. His unparalleled experience and expertise in biostatistics, data analysis, and the pharmaceutical industry is extremely valuable to us, and further strengthens the knowledge base we already have within the Group.”
Modern healthcare is also generating a huge amount of data. The problem is that it is much better at producing data than it is at capturing the relevant data and use it to help their customers, the patients. Which is where we come in. You might say that our mission is to help healthcare create health by using what they already have at their disposal: Healthcare generated data. Our best services have been crafted in close cooperation with our customers and if you have ideas we want to hear about them as soon as possible. Below are our guesses on who you are, we would be equally happy if we are right or if you prove us wrong, as long as you have interesting stuff to discuss with us. If you have found your way here chances are that you are a healthcare professional, working at a pharmaceutical company or that you, as we do, deliver services to the healthcare and pharmaceutical industry. You are probably interested in providing better service for your customers.